Multibase India Ltd vs Rossari Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of Multibase India Ltd is ₹ 167 as of 18 Mar 15:31 . The P/E Ratio of Multibase India Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Rossari Biotech Ltd changed from 67.2 on March 2021 to 24.5 on March 2025 . This represents a CAGR of -18.27% over 5 years The Market Cap of Multibase India Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Rossari Biotech Ltd changed from ₹ 5388 crore on March 2021 to ₹ 3344 crore on March 2025 . This represents a CAGR of -9.10% over 5 years The revenue of Multibase India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Rossari Biotech Ltd for the Dec '25 is ₹ 582.59 crore as compare to the Sep '25 revenue of ₹ 588.18 crore. This represent the decline of -0.95% The ebitda of Multibase India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Rossari Biotech Ltd for the Dec '25 is ₹ 69.78 crore as compare to the Sep '25 ebitda of ₹ 74 crore. This represent the decline of -5.7% The net profit of Multibase India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Rossari Biotech Ltd changed from ₹ 34.9 crore to ₹ 32.77 crore over 7 quarters. This represents a CAGR of -3.53% The Dividend Payout of Multibase India Ltd changed from 37.56 % on March 2021 to 456.56 % on March 2025 . This represents a CAGR of 64.80% over 5 yearsThe Dividend Payout of Rossari Biotech Ltd changed from 3.28 % on March 2021 to 2.41 % on March 2025 . This represents a CAGR of -5.98% over 5 years .

About Multibase India Ltd

Multibase India Limited was incorporated as Synergy Polymers Limited on 17th December, 1991.
In 1999, the name of Company was changed to Synergy Mulitibase Limited and further to Multibase India Limited on August 31, 2007. Multibase India Ltd is part of the Multibase SA Group, a leading compounder in Europe, the USA and India.
In 2002, the Company was acquired by Multibase SA, subsidiary of Dow Corning Corporation and thus became a Dow corning Company. The company is engaged in in manufacturing, trading and selling of polypropylene compound, thermoplastic elastomer, silicon master batch and thermoplastic master batch.
It is a diverse yet integrated manufacturing company of thermoplastic elastomers and silicone-based products. The Company's products include Silicon-Based Thermoplastics, TPSiV Multiplex, Thermoplastic-Elastomer (TPE physically blends), Triethyl silane (TES) Multiplex Range of Products.

About Rossari Biotech Ltd

Rossari Biotech Limited was founded in 2003 as a partnership firm in the name of Rossari Labtech by Mr. Edward Walter Menezes, and Mr. Sunil Srinivasan Chari, who are both career-technocrats cumulatively having over 45 years of experience in the specialty chemicals industry.
It was further renamed to Rossari Biotech Limited and converted into a company in 2009.
The Company has two state-of-the art facilities at Dahej, Gujarat and Silvassa, Dadra Nagar & Haveli and is mainly engaged in manufacturing, selling and distribution of specialty chemicals.
The products cater to global brands in the FMCG sector and find applications in a host of consumer-centric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products. During the FY2020, 50,00,000 equity shares of face value of Rs 10 each was sub-divided into 2,50,00,000 Equity Shares of face value of Rs 2 each.

FAQs for the comparison of Multibase India Ltd and Rossari Biotech Ltd

Which company has a larger market capitalization, Multibase India Ltd or Rossari Biotech Ltd?

Market cap of Multibase India Ltd is 358 Cr while Market cap of Rossari Biotech Ltd is 2,343 Cr

What are the key factors driving the stock performance of Multibase India Ltd and Rossari Biotech Ltd?

The stock performance of Multibase India Ltd and Rossari Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Multibase India Ltd and Rossari Biotech Ltd?

As of March 18, 2026, the Multibase India Ltd stock price is INR ₹283.8. On the other hand, Rossari Biotech Ltd stock price is INR ₹423.15.

How do dividend payouts of Multibase India Ltd and Rossari Biotech Ltd compare?

To compare the dividend payouts of Multibase India Ltd and Rossari Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.